ArticleJDS communications2026
In vitro dose-response of bromoform stabilized in vegetable oil on rumen fermentation and methane production.
Article in JDS communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetically manufactured bromoform may provide a sustainable and economically viable alternative to macroalgae harvesting and cultivation for mitigating methane emissions in ruminants. Our objective was to evaluate the effect of varying doses of synthetic bromoform stabilized in vegetable oil on rumen fermentation, digestibility, and methane production using an in vitro batch culture system. Four treatments were evaluated: 0 (BR0), 1,000 (BR1), 2,500 (BR2), and 5,000 (BR5) mg bromoform/kg oil, added to batch culture vessels at a 2% DM basis. A randomized complete block design was applied across 3 periods, with incubations conducted for 3, 6, 12, 24, and 72 h in each period. Treatments were replicated 3 times at each incubation time. At 72 h, methane (mg/g of disappeared DM) was reduced by 32.3%, 96.4%, and 100% in BR1, BR2, and BR5, respectively, compared with BR0. The inclusion of bromoform at varying doses did not influence fermentation medium pH or apparent substrate disappearance, as measured by DM, NDF, and ADF disappearance. Bromoform inclusion modified the ruminal VFA profile. At 12 h, BR2 and BR5 treatments exhibited decreased acetate concentrations relative to BR1, whereas at 24 h, these treatments had reduced acetate concentrations compared with BR0. Moreover, by 72 h, BR5 had the lowest acetate concentrations among treatments. The acetate-to-propionate ratio was lesser in BR5 and marginally lesser in BR2 compared with BR0. Butyrate concentration was greater in BR1 and BR5 compared with BR0. At 72 h, BR2 and BR5 showed greater concentrations of valerate and caproate concomitant with a decrease in isobutyrate concentrations relative to BR0 and BR1. Isovalerate and 2-methylbutyrate concentrations were greater in BR1 compared with BR2 and BR5. The collective findings of this study indicate that synthetic bromoform inclusion (BR2 and BR5) markedly reduced methane production, preserved digestibility, and altered rumen fermentation characteristics, suggesting a compensatory shift in reducing equivalents utilization by the rumen microbiota.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.